Aethlon Medical Inc
AEMD Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$5.15
KIRA · Stoqly’s AI analyst, in plain words
- Aethlon Medical Inc lost $7.2M in fiscal 2026.
- Free cash flow was −$7.0M in fiscal 2026, — of revenue.
Market cap
$2.0M
P/E
0.2x
Revenue
—
Net income
−$7.2M
Free cash flow
−$7.0M
Operating margin
—
Aethlon Medical Inc in 30 seconds · fiscal 2026
Does it make a profit?
−$7.2M
No. It lost money last year.
How is the share priced?
0.2x
One share costs 0.2 times its yearly profit per share.
What Aethlon Medical Inc does
No business description yet.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K · Jun 10, 2026
- Legal name
- AETHLON MEDICAL INC
- CIK
- 0000882291
Aethlon Medical Inc · AEMD
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.3M | $0.6M | $0.0M | — | — |
| Revenue growth | −55.4% | 95.2% | −100.0% | — | — |
| Operating margin | −3,542.1% | −2,072.2% | — | — | — |
| Net income | −$10.4M | −$12.0M | −$12.2M | −$13.4M | −$7.2M |
| Net margin | −3,540.5% | −2,095.1% | — | — | — |
| Diluted EPS | −$0.71 | −$5.86 | −$38.87 | −$85.77 | −$10.61 |
| Cash | |||||
| Cash from operations | −$9.8M | −$10.5M | −$10.1M | −$7.6M | −$7.0M |
| Capital expenditure | $0.3M | $0.9M | $0.3M | $0.0M | $0.0M |
| Free cash flow | −$10.1M | −$11.4M | −$10.4M | −$7.6M | −$7.0M |
| FCF margin | −3,438.6% | −1,993.8% | — | — | — |
| Share count change | 22.1% | −86.1% | −84.7% | −50.3% | 331.7% |
| Debt and strength | |||||
| Cash and short-term investments | $17.1M | $14.5M | $5.4M | $5.5M | $5.0M |
| Shareholders' equity | $17.0M | $15.1M | $5.8M | $5.1M | $4.9M |
| Current ratio | 10.0x | 10.0x | 3.4x | 3.1x | 3.8x |
| Interest coverage | — | — | — | −924.9x | −506.5x |
| Returns and quality | |||||
| Return on equity | −78.8% | −75.1% | −117.2% | −245.9% | −142.9% |
| Return on tangible equity | −61.3% | −79.9% | −211.8% | −261.3% | −146.4% |
| Piotroski F-score | 3 | 4 | 2 | — | — |
| Altman Z'' | −12.6 | −19.5 | −65.5 | −76.9 | −90.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Aethlon Medical Inc · AEMD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $5.15 a share, the company is worth $2.0M: 0.2 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0000882291). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.